Using a multidisciplinary strategy, C. pyrenoidosa protein was investigated as a source of peptides active against ACE and DPP-IV targets, in line with the preclinical and clinical evidences suggesting that the consumption of C. pyrenoidosa may be useful for the prevention of cardiovascular disease. This evidence concerns the gene DPP4 and cardiovascular disorder.